Clinical trial
Hyperbaric Oxygen Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - A Prospective, Randomized, Double-Blind, Sham-Controlled Study
NCT07621068 is registered in ClinicalTrials.gov with Assaf-Harofeh Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hyperbaric Oxygen Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - A Prospective, Randomized, Double-Blind, Sham-Controlled Study
- Lead sponsor
- Assaf-Harofeh Medical Center
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 19, 2026
- Completion date
- June 30, 2027
- Enrollment
- 74 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic fatigue syndrome, me/cfs